@article{Derkach_Butko_Nehretskii_2021, title={Evidence-based pharmacy: obtaining and studying of aescine from the plant of aesculus hippocastanum l.}, volume={1}, url={https://ssp.ee/index.php/mpm/article/view/10}, DOI={10.53933/sspmpm.v1i1.10}, abstractNote={<p>The quality and life expectancy of the population depends on the level of access to modern, <strong>high quality</strong>, effective and evidence-based medical and pharmaceutical care. These types of care play a significant role in the pharmacotherapy of cardiovascular diseases, which are one of the main medical, biological and socio-economic problems of society. The main nosologies that cause high mortality from cardiovascular disease are heart attacks, strokes, sudden death syndrome and cardiomyopathy, which are preceded by such pathological conditions as hypertension, life-threatening arrhythmias, angina, chronic venous insufficiency. The aim of the study was to obtain and study <strong>a</strong>escin<strong>e</strong> from the amniotic fluid of Aesculus hippocastanum L. The pericarp of the plant Aesculus hippocastanum L. as a source of <strong>a</strong>escin<strong>e</strong> was studied. As a vegetable raw material for the production of <strong>a</strong>escin<strong>e</strong> we used amniotic horse chestnut. A new method for the isolation of <strong>a</strong>escin<strong>e</strong> by its extraction from horse chestnut n-butanol saturated with water, followed by purification of the target product with aluminum oxide. The amniotic fluid of horse chestnut on the content of <strong>a</strong>escin<strong>e</strong> w<strong>ere</strong> studied. <strong>F</strong>ound that the content o in this raw material ranges from 1.5% to 2.5%.</p>}, number={1}, journal={SSP Modern Pharmacy and Medicine}, author={Derkach, Anatolii and Butko, Alina and Nehretskii, Serhii}, year={2021}, month={Aug.}, pages={1–7} }